CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 103 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,661,000 | +57.2% | 611,273 | +8.8% | 0.00% | +50.0% |
| Q1 2021 | $13,141,000 | -8.4% | 561,845 | +12.8% | 0.00% | 0.0% |
| Q4 2020 | $14,348,000 | +55.0% | 498,208 | +9.0% | 0.00% | 0.0% |
| Q3 2020 | $9,258,000 | -20.8% | 457,004 | +17.5% | 0.00% | -33.3% |
| Q2 2020 | $11,688,000 | +30.1% | 388,968 | +36.1% | 0.00% | +50.0% |
| Q1 2020 | $8,982,000 | -57.9% | 285,789 | -36.9% | 0.00% | 0.0% |
| Q4 2019 | $21,322,000 | +2950.4% | 452,654 | +317.9% | 0.00% | – |
| Q3 2019 | $699,000 | -45.9% | 108,318 | +2.9% | 0.00% | – |
| Q2 2019 | $1,292,000 | +6.5% | 105,234 | +17.5% | 0.00% | – |
| Q1 2019 | $1,213,000 | +1002.7% | 89,587 | +226.1% | 0.00% | – |
| Q4 2018 | $110,000 | +39.2% | 27,470 | +133.8% | 0.00% | – |
| Q3 2018 | $79,000 | – | 11,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |